Titusville, NJ, United States of America

Peter Egli


Average Co-Inventor Count = 2.6

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1983-1992

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Peter Egli

Introduction

Peter Egli is a notable inventor based in Titusville, NJ (US). He has made significant contributions to the field of chemistry, particularly in the development of novel compounds with various applications. With a total of 3 patents to his name, Egli's work has garnered attention in both academic and industrial circles.

Latest Patents

Egli's latest patents include innovative compounds that have potential therapeutic applications. One of his notable inventions is related to Piperidinyl carbonyl derivatives. These novel compounds, characterized by a specific general formula, are designed as CNS agents with anxiogenic activity. Another significant patent involves Nitrobenzofuran derivatives, which are useful analytical tools. These compounds are defined by a specific formula, where various substituents can be hydrogen, lower alkyl, or phenyl-lower alkyl, showcasing Egli's versatility in chemical innovation.

Career Highlights

Peter Egli is currently associated with E. R. Squibb Sons, Inc., where he continues to push the boundaries of chemical research and development. His work at this esteemed company has allowed him to explore various avenues in pharmaceutical chemistry, contributing to advancements in the field.

Collaborations

Throughout his career, Egli has collaborated with talented individuals such as Callixtus E Ita and Anthony F Heald. These collaborations have enriched his research and have led to the development of impactful inventions.

Conclusion

Peter Egli's contributions to the field of chemistry through his patents and collaborations highlight his innovative spirit and dedication to advancing scientific knowledge. His work continues to influence the development of new compounds with significant applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…